Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping

NCT07250737 is registered in ClinicalTrials.gov with Avidity Biosciences, Inc. as lead sponsor.

NCT NCT07250737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07250737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping
Lead sponsor
Avidity Biosciences, Inc.
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

genetic diseases, inborn, genetic diseases, x-linked, muscular diseases, muscular disorders, atrophic, muscular dystrophies, muscular dystrophy, duchenne, musculoskeletal diseases, nervous system diseases, neuromuscular diseases